288 related articles for article (PubMed ID: 29360950)
21. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.
Feuerstadt P; Nelson WW; Drozd EM; Dreyfus J; Dahdal DN; Wong AC; Mohammadi I; Teigland C; Amin A
J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and impact of Clostridium difficile recurrence on haematology patients.
Scappaticci GB; Perissinotti AJ; Nagel JL; Bixby DL; Marini BL
J Antimicrob Chemother; 2017 May; 72(5):1488-1495. PubMed ID: 28186243
[TBL] [Abstract][Full Text] [Related]
23. Mortality and Costs in Clostridium difficile Infection Among the Elderly in the United States.
Shorr AF; Zilberberg MD; Wang L; Baser O; Yu H
Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1331-1336. PubMed ID: 27572289
[TBL] [Abstract][Full Text] [Related]
24. Economic healthcare costs of Clostridium difficile infection: a systematic review.
Ghantoji SS; Sail K; Lairson DR; DuPont HL; Garey KW
J Hosp Infect; 2010 Apr; 74(4):309-18. PubMed ID: 20153547
[TBL] [Abstract][Full Text] [Related]
25. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Kimura T; Snijder R; Sugitani T
J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
[TBL] [Abstract][Full Text] [Related]
26. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
[TBL] [Abstract][Full Text] [Related]
27. The Economic Burden of Hospital-Acquired Clostridium difficile Infection: A Population-Based Matched Cohort Study.
Nanwa N; Kwong JC; Krahn M; Daneman N; Lu H; Austin PC; Govindarajan A; Rosella LC; Cadarette SM; Sander B
Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1068-78. PubMed ID: 27322606
[TBL] [Abstract][Full Text] [Related]
28. Consequences of Clostridium difficile infection: understanding the healthcare burden.
Bouza E
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():5-12. PubMed ID: 23121549
[TBL] [Abstract][Full Text] [Related]
29. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland.
Robertson C; Pan J; Kavanagh K; Ford I; McCowan C; Bennie M; Marwick C; Leanord A
J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202
[TBL] [Abstract][Full Text] [Related]
30. Utilization of Health Services Among Adults With Recurrent Clostridium difficile Infection: A 12-Year Population-Based Study.
Kuntz JL; Baker JM; Kipnis P; Li SX; Liu V; Xie Y; Marcella S; Escobar GJ
Infect Control Hosp Epidemiol; 2017 Jan; 38(1):45-52. PubMed ID: 27760583
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care.
Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ
Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
[TBL] [Abstract][Full Text] [Related]
33. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.
Asensio A; Di Bella S; Lo Vecchio A; Grau S; Hart WM; Isidoro B; Scotto R; Petrosillo N; Watt M; Nazir J
Int J Infect Dis; 2015 Jul; 36():31-8. PubMed ID: 26003403
[TBL] [Abstract][Full Text] [Related]
34. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study.
Tabak YP; Zilberberg MD; Johannes RS; Sun X; McDonald LC
Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889
[TBL] [Abstract][Full Text] [Related]
35. Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study.
Bouza E; Cobo J; Rodríguez-Hernández MJ; Salavert M; Horcajada JP; Iribarren JA; Obi E; Lozano V; Maratia S; Cuesta M; Uría E; Limón E
Rev Esp Quimioter; 2021 Apr; 34(2):126-135. PubMed ID: 33618513
[TBL] [Abstract][Full Text] [Related]
36. The economic burden of Clostridium difficile.
McGlone SM; Bailey RR; Zimmer SM; Popovich MJ; Tian Y; Ufberg P; Muder RR; Lee BY
Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576
[TBL] [Abstract][Full Text] [Related]
37. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection.
Wiegand PN; Nathwani D; Wilcox MH; Stephens J; Shelbaya A; Haider S
J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638
[TBL] [Abstract][Full Text] [Related]
38. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.
Zhang S; Palazuelos-Munoz S; Balsells EM; Nair H; Chit A; Kyaw MH
BMC Infect Dis; 2016 Aug; 16(1):447. PubMed ID: 27562241
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.
Zilberberg MD; Reske K; Olsen M; Yan Y; Dubberke ER
BMC Infect Dis; 2014 Jun; 14():306. PubMed ID: 24898123
[TBL] [Abstract][Full Text] [Related]
40. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
